NCT07306559
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07306559
Title A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Valkyrie Clinical Trials Los Angeles California 90067 United States Details
Indiana University Indianapolis Indiana 46202 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Cliniques Universitaires Saint-Luc Brussels 1200 Belgium Details
UZ Leuven Leuven 3000 Belgium Details
INS Paoli-Calmettes Marseille 13009 France Details
INS Gustave Roussy Villejuif 94800 France Details
Klinikum der Universität München AÖR München 81377 Germany Details
Universitätsklinikum Würzburg AÖR Würzburg 97078 Germany Details
National Cancer Center Hospital East Chiba, Kashiwa 277-8577 Japan Details
Japanese Foundation for Cancer Research Tokyo, Koto-ku 135-8550 Japan Details
Hospital Universitari Vall D Hebron Barcelona 08035 Spain Details
Clínica Universidad de Navarra - Madrid Madrid 28027 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field